Trials / Completed
CompletedNCT01020526
Pregabalin In Adolescent Patients With Fibromyalgia
A 6-month, Open-label, Safety Trial Of Pregabalin In Adolescent Patients With Fibromyalgia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the long-term safety of pregabalin in adolescent patients who participated in the previous fibromyalgia study (A0081180) and who wish to recieve open-label pregabalin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin | Oral capsule 75-450 mg/day |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2009-11-25
- Last updated
- 2021-01-28
- Results posted
- 2016-07-01
Locations
26 sites across 3 countries: United States, Czechia, India
Source: ClinicalTrials.gov record NCT01020526. Inclusion in this directory is not an endorsement.